ClouDr Group’s Hong Kong IPO Nets HKD 482 Million with Sanofi as Investor
Hangzhou-based ClouDr Group Ltd (HKG: 9955), a one-stop chronic disease management and smart medical platform,...
IPO
Luzhu Bio Files for Hong Kong IPO After RMB 4.42 Billion Valuation
Beijing Luzhu Biotechnology Co., Ltd, a leading developer of human vaccines and therapeutic biologics, has...
MicroPort NeuroTech Lists in Hong Kong with $43.3 Million IPO
MicroPort NeuroTech Limited has successfully completed its initial public offering (IPO) on the Hong Kong...
ImmuneOnco Biopharmaceuticals Files for HKSE IPO with Comprehensive Tumor Immunotherapy Pipeline
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd has submitted an initial public offering (IPO) filing to the...
Guangzhou Baiyunshan Halts Spinning-off of Guangzhou Pharmaceutical Amid HK Capital Shifts
China-based Guangzhou Baiyunshan Pharmaceutical Co., Ltd (SHA: 600332) has announced the suspension of the spinning-off...
Suzhou Teligene Ltd Plans IPO on Shanghai STAR Market for Cancer Drug Development
China-based Suzhou Teligene Ltd has announced plans for an initial public offering (IPO) of 63.52...
Mega Genomics Limited Makes Hong Kong IPO Debut at HKD 18 Per Share
China-based gene testing platform company Mega Genomics Limited has successfully completed an initial public offering...
Beijing Winsunny Pharma Plans IPO to Boost Drug Development and Production
China-based Beijing Winsunny Pharmaceutical Co., Ltd. has announced plans for an initial public offering (IPO)...